tiprankstipranks
Glenmark Life Sciences Limited (IN:ALIVUS)
:ALIVUS
India Market
ALIVUS
Glenmark Life Sciences Limited
RESEARCH TOOLSreports
Want to see IN:ALIVUS full AI Analyst Report?

Glenmark Life Sciences Limited (ALIVUS) Financial Statements

4 Followers

Glenmark Life Sciences Limited Financial Overview

Glenmark Life Sciences Limited's market cap is currently ₹127.15B. The company's EPS TTM is ₹22.173; its P/E ratio is 18.41; and it has a dividend yield of 0.56%. Glenmark Life Sciences Limited is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 25.52B₹ 22.83B₹ 21.61B₹ 18.85B₹ 15.37B
Gross Profit₹ 11.37B₹ 12.43B₹ 11.47B₹ 9.80B₹ 8.47B
Operating Income₹ 7.22B₹ 8.98B₹ 6.01B₹ 5.62B₹ 4.44B
EBITDA₹ 7.97B₹ 6.86B₹ 6.71B₹ 5.92B₹ 4.84B
Net Income₹ 5.64B₹ 4.71B₹ 4.67B₹ 3.52B₹ 3.13B
Balance Sheet
Cash & Short-Term Investments₹ 7.83B₹ 3.01B₹ 3.80B₹ 1.40B₹ 307.68M
Total Assets₹ 39.83B₹ 28.50B₹ 27.02B₹ 19.97B₹ 17.26B
Total Debt₹ 567.71M₹ 171.48M₹ 193.57M₹ 9.33B₹ 210.00K
Net Debt₹ 546.39M₹ -2.84B₹ -2.64B₹ 8.17B₹ -99.77M
Total Liabilities₹ 6.51B₹ 5.18B₹ 5.64B₹ 12.44B₹ 13.24B
Stockholders' Equity₹ 33.32B₹ 23.32B₹ 21.38B₹ 7.53B₹ 4.02B
Cash Flow
Free Cash Flow₹ 2.59B₹ 2.85B₹ 1.43B₹ 3.20B₹ 1.44B
Operating Cash Flow₹ 5.66B₹ 4.14B₹ 3.13B₹ 3.88B₹ 1.95B
Investing Cash Flow₹ -5.71B₹ -1.16B₹ -1.54B₹ -687.34M₹ -505.18M
Financing Cash Flow₹ -641.34M₹ -2.79B₹ -3.88B₹ -2.14B₹ -1.37B
Currency in INR

Glenmark Life Sciences Limited Earnings and Revenue History

Income Statement >

Glenmark Life Sciences Limited Debt to Assets

Balance Sheet >

Glenmark Life Sciences Limited Cash Flow

Cash Flow >

Glenmark Life Sciences Limited Forecast EPS vs Actual EPS

Earnings >